Keynote and Invited speakers

speaker3 Marc Dalod

Team leader ‘Dendritic cells and antiviral defense'
CIML
CNRS
Marseille
France
dalod@ciml.univ-mrs.fr

Dr Dalod is heading the team “Dendritic cells and antiviral defense” at the Centre d'Immunologie de Marseille-Luminy (CIML) in Marseille, France. Currently, he is also the CIML deputy director (2015-2017).

His investigations are mainly focused on understanding which subsets of dendritic cells (DC) promote protective antiviral or anti-tumoral immunity, and how, during natural history of diseases or upon different types of therapies. In this frame, he is also investigating the molecular bases of the functional polarization of DC subsets towards immunity versus tolerance.

He trained for Ph.D. under the supervision of Dr. Elisabeth Gomard and Jean-Gérard Guillet, at Cochin Hospital, in Paris, France, from 1996 to 2000, studying CD8+ T cell responses to human immunodeficiency virus type 1 (HIV-1). He discovered that anti-HIV-1 CD8+ T cell responses appear to be delayed and blunted during primary infection as compared to responses described against acute infections with Epstein-Barr virus or Measles virus (Dalod et al. J Clin. Invest. 1999). He hypothesized that HIV-1 infection was compromising the cross-talk between innate and adaptive immunity. Thus, he decided to join the laboratory of Pr. Christine A. Biron (Brown University, Providence, RI, USA) to perform his post-doctoral training examining the role of DC subsets and natural killer cells in antiviral immunity in mice, from 2000 to 2002. There, in collaboration with Giorgio Trinchieri, Carine Asselin-Paturel and colleagues (Schering-Plough, Dardilly, France), he contributed to the discovery and first in vivo functional study of mouse plasmacytoid DC (Asselin-Paturel et al. Nat. Immunol. 2001; Dalod et al. J Exp Med. 2002; Dalod et al. J Exp Med. 2003). Since then, he has been using mouse cytomegalovirus (MCMV) infection as a lead model to dissect the role of mononuclear phagocytes in antiviral immune responses. In 2003 he joined the CIML where he has been leading a team since 2004.


Sessions

Volledige programa

CMV 2017: the 6th International congenital CMV conference/16th International CMV/betaherpesvirus workshop in 2017<